SEC Filings

Form 6-K
AURIS MEDICAL HOLDING AG filed this Form 6-K on 03/14/2017
Document Outline
Entire Document (986.3 KB)
Subdocument 1 - 6-K - FORM 6-K
Page 1 - UNITED STATES
Page 2 - SIGNATURE
Page 3 - EXHIBIT INDEX
Subdocument 2 - EX-99.1 - EXHIBIT 99.1
Page 1 - Exhibit 99.1
Page 2 - AM-125 for Meniere s Disease and Vestibular Vertigo
Page 3 - Annual General Meeting
Page 4 - About Auris Medical
Page 5 - Forward-looking Statements
Page 6 - Consolidated Statement of Profit or Loss and Other Comprehensive Loss
Page 7 - Consolidated Statement of Financial Position
Subdocument 3 - EX-99.2 - EXHIBIT 99.2
Page 1 - Auris Medical Holding AG
Page 2 - Invitation to the Annual General Meeting of Shareholders
Page 3 - Article 3b Conditional Share Capital for Financing Purposes
Page 4 - N/A
Page 5 - Organizational Matters
Page 6 - Einladung zur ordentlichen Generalversammlung
Page 7 - Artikel 3b Abs. 1 Bedingtes Kapital zu Finanzierungszwecken
Page 8 - N/A
Page 9 - Organisatorische Hinweise
Page 10 - N/A
Subdocument 4 - EX-99.3 - EXHIBIT 99.3
Page 1 - Exhibit 99.3
Page 2 - Statutory Auditor s Report
Page 3 - Key Audit Matters
Page 4 - N/A
Page 5 - N/A
Page 6 - Other Information in the Annual Report
Page 7 - Auditor s Responsibilities for the Audit of the Consolidated Financial Statements
Page 8 - Consolidated Statement of Profit or Loss and Other Comprehensive Loss
Page 9 - Consolidated Statement of Financial Position
Page 10 - Consolidated Statement of Changes in Equity
Page 11 - Consolidated Statement of Cash Flows
Page 12 - 1. Reporting entity
Page 13 - Income taxes
Page 14 - Foreign currency
Page 15 - Intangible assets
Page 16 - Financial instruments
Page 17 - Impairment of non-derivative financial assets
Page 18 - Employee benefits
Page 19 - Provisions
Page 20 - 5. Financial instruments and risk management
Page 21 - Credit risk
Page 22 - Interest rate risk
Page 23 - 8. Intangible assets
Page 24 - 11. Cash and cash equivalents
Page 25 - Authorized share capital
Page 26 - Measurement of fair values
Page 27 - 15. Accrued expenses
Page 28 - Benefit plans
Page 29 - Change in fair value of plan assets
Page 30 - Sensitivity analysis
Page 31 - N/A
Page 32 - N/A
Page 33 - 21. Loss per share
Page 34 - Controlled Equity OfferingSM
Page 35 - 25. Events after the balance sheet date
Subdocument 5 - EX-99.4 - EXHIBIT 99.4
Page 1 - Exhibit 99.4
Page 2 - Report of the statutory auditor
Page 3 - Opinion
Page 4 - N/A
Page 5 - Verordnung gegen berm ssige Verg tungen bei b rsenkotierten Aktiengesellschaften
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Subdocument 6 - EX-99.5 - EXHIBIT 99.5
Page 1 - Exhibit 99.5
Page 2 - Report of the Statutory Auditor
Page 3 - Responsibility of the Board of Directors for the Financial Statements
Page 4 - Auditor s Responsibilities for the Audit of the Financial Statements
Page 5 - AURIS MEDICAL HOLDING AG, ZUG
Page 6 - AURIS MEDICAL HOLDING AG, ZUG
Page 7 - AURIS MEDICAL HOLDING AG, ZUG
Page 8 - AURIS MEDICAL HOLDING AG, ZUG
Page 9 - AURIS MEDICAL HOLDING AG, ZUG
Page 10 - AURIS MEDICAL HOLDING AG, ZUG
Page 11 - AURIS MEDICAL HOLDING AG, ZUG
Page 12 - AURIS MEDICAL HOLDING AG, ZUG
Page 13 - AURIS MEDICAL HOLDING AG, ZUG